Here are the 10-K annual reports from Balchem Corporation (BCPC) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-K covers the audited annual report, with the full financial statements, so if you follow BCPC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BCPC filings page.
Balchem Corporation filed its annual report describing a diversified specialty ingredients business across Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The company serves food, beverage, pharmaceutical, animal health, plant nutrition and industrial markets worldwide.
Backlog was $53,365 thousand at December 31, 2025, modestly above $50,415 thousand a year earlier, with all orders expected to ship in 2026. Balchem invested $43,193 thousand in capital projects and $18,510 thousand in R&D during 2025 to expand capacity, improve efficiency and develop new products.
The company highlights regulatory and environmental exposure around ethylene oxide and propylene oxide, global supply chain and geopolitical risks, cybersecurity threats, labor availability, and raw material inflation. As of year-end 2025 Balchem employed about 1,352 full-time staff worldwide and continued share repurchases, buying back 684,927 shares during 2025.